Invest now
Alembic Pharmaceuticals share price
Balanced risk
- ₹844.65(-0.64%)July 16, 2026 15:29:35 PM IST
- NSE
- BSE
- Vol : 101.76 K (NSE + BSE)Last 20 day avg : 192.22 K
Alembic Pharmaceuticals is trading -0.64% lower at Rs 844.65 as compared to its last closing price. Alembic Pharmaceuticals has been trading in the price range of 855.70 & 837.65. Alembic Pharmaceuticals has given 0.46% in this year & 4.78% in the last 5 days. Alembic Pharmaceuticals has TTM P/E ratio 19.32 as compared to the sector P/E of 25.82.There are 9 analysts who have initiated coverage on Alembic Pharmaceuticals. There are 3 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 202.70 Crores in its last quarter.Listed peers of Alembic Pharmaceuticals include Sun Pharmaceutical Industries (-0.06%), Dr Reddy's Laboratories (-0.48%), Divi's Laboratories (0.48%).The Mutual Fund holding in Alembic Pharmaceuticals was at 8.73% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Alembic Pharmaceuticals was at 4.17% in 30 Jun 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 17 Jul 2026, 02:34 AM IST
- BetaMedium volatility0.94Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.25The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry1.41Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.97The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Alembic Pharmaceuticals News
Alembic Pharmaceuticals Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,951.30 | -0.06 | 4,68,171.21 | 36.24 | 5.77 | 0.92 | 0.50 |
| Dr Reddy's Laboratories | 1,223.90 | -0.48 | 1,02,151.19 | 18.63 | 3.14 | 0.63 | 2.34 |
| Divi's Laboratories | 7,319.75 | 0.48 | 1,94,316.36 | 78.61 | 11.52 | 0.46 | 0.01 |
| Cipla | 1,428.00 | -0.69 | 1,15,360.31 | 22.95 | 3.87 | 0.87 | 0.81 |
| Torrent Pharmaceuticals | 5,002.75 | -0.30 | 1,69,368.61 | 67.32 | 17.1 | 0.83 | 17.62 |
Mutual Fund Ownership
View allAlembic Pharmaceuticals Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-04 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-06 | Audited Results & Final Dividend |
About the company Alembic Pharmaceuticals
- IndustryBiotechnology & Drugs
- ISININE901L01018
- BSE Code533573
- NSE CodeAPLLTD
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.
Alembic Pharmaceuticals Share Price FAQs
Alembic Pharmaceuticals is trading at 844.65 as on Thu Jul 16 2026 09:59:35. This is -0.64% lower as compared to its previous closing price of 850.10.
The market capitalization of Alembic Pharmaceuticals is 16576.45 Cr as on Thu Jul 16 2026 09:59:35.
The average broker rating on Alembic Pharmaceuticals is Buy. The breakup of analyst rating is given below -
- 3 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 5 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Alembic Pharmaceuticals is 1064.70 whereas the 52 wk low is 635.30
Alembic Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 19.32
- Sector P/E: 25.82
- Dividend Yield: 1.41%
- D/E ratio: 0.25
Alembic Pharmaceuticals reported a net profit of 674.77 Cr in 2026.
The Mutual Fund Shareholding was 8.73% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Alembic Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.